Ketamine is a phencyclidine derivative, which functions primarily as an antagonist of the N- methyl-d-aspartate receptor. It has no affinity for gamma-aminobutyric acid receptors in the …
R Chou, DB Gordon, OA de Leon-Casasola… - The journal of pain, 2016 - Elsevier
Most patients who undergo surgical procedures experience acute postoperative pain, but evidence suggests that less than half report adequate postoperative pain relief. Many …
Background Ketamine infusions have been used for decades to treat acute pain, but a recent surge in usage has made the infusions a mainstay of treatment in emergency …
N Rawal - European Journal of Anaesthesiology| EJA, 2016 - journals.lww.com
Postoperative pain has been poorly managed for decades. Recent surveys from USA and Europe do not show any major improvement. Persistent postoperative pain is common after …
P Richebé, X Capdevila, C Rivat - Anesthesiology, 2018 - pubs.asahq.org
The development of chronic pain is considered a major complication after surgery. Basic science research in animal models helps us understand the transition from acute to chronic …
S Kohtala - Pharmacological Reports, 2021 - Springer
Over the past 50 years, ketamine has solidified its position in both human and veterinary medicine as an important anesthetic with many uses. More recently, ketamine has been …
AW Gorlin, DM Rosenfeld… - Journal of …, 2016 - journals.lww.com
Ketamine, an N-methyl-d-aspartate antagonist, blunts central pain sensitization at sub- anesthetic doses (0.3 mg/kg or less) and has been studied extensively as an adjunct for …
P Thapa, P Euasobhon - The Korean journal of pain, 2018 - synapse.koreamed.org
Chronic postsurgical pain (CPSP) is an unwanted adverse event in any operation. It leads to functional limitations and psychological trauma for patients, and leaves the operative team …
RF Bell, EA Kalso - Pain reports, 2018 - journals.lww.com
Ketamine is commonly used as an analgesic in emergency medicine and as an adjuvant drug in the perioperative setting. In addition, it is used as a third-line adjuvant drug for opioid …